Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Two Occlusion Technology Dentifrices in Dentinal Hypersensitivity
NCT07317128Completed
- Sponsor
- Haleon
- Start
- Jan 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of GSK Experimental Dentifrice MFC02753 in dentin hypersensitivity (DH) (3 arms), sponsored by Haleon. Primary endpoint: Schiff Sensitivity Score at 12 weeks. Started Jan 2013; status: completed.
02
Drugs
GSK Experimental Dentifrice MFC02753
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT07317128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07317128.